🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 28% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
28% Evidence Coverage

Supplement Facts — Evidence Check

5 mg (31% DV)
✅ Within RDA (0.4× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 5mg UL 35mg
15 mg (136% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg
Eurycoma longifolia
100 mg
Epimedium extract
50 mg
Cnidium, Powder
25 mg
Velvet Bean Extract
25 mg
📊 Market median: 495.0mg (70 products)
Median 495.0mg This product: 150mg
📊 Market median: 50.0mg (57 products) 📚 17 studies — no high-quality reviews
This product: 50mg UL 50mg
📊 Market median: 450.0mg (390 products) 📚 155 studies (Tier A: 0, B: 63)
This product: 15mg
Eleuthero Root Extract
15 mg
Oat Straw extract
50 mg
📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)
This product: 50mg
📊 Market median: 300.0mg (122 products) 📚 22 studies (Tier A: 0, B: 7)
This product: 5mg
Chinese Yam extract
100 mg
📊 Market median: 500.0mg (357 products) 📚 1 studies — no high-quality reviews
This product: 50mg
25 mg
📊 Market median: 500.0mg (143 products)
This product: 25mg
Tribulus Fruit, Seed Extract
15 mg
Muira Puama, Powder
15 mg

Other Ingredients

Calcium Carbonate Croscarmellose Sodium Microcrystalline Cellulose Stearic Acid Hydroxypropylmethylcellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

📋 Directions for Use

Directions (Men): Take 1 tablet daily preferably with food 1 to 2 hours prior to physical activity or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Caution: Not for use by individuals under the age of 18 years.

Consult a healthcare professional before using this product if you have or have a family history of breast cancer, prostate cancer, prostate enlargement, heart disease, low "good" cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effect includes acne, hair loss, aggressiveness, irritability, and increased level of estrogen. Discontinue use and call a healthcare professional immediately if you experience rapid heartbeat, dizziness, blurred vision, flushed skin (niacin), or other symptoms.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, fish and crustacean shellfish.

Keep out of the reach of children

Do not use if seal is broken

🧪 Formulation Notes

Non-GMO formula for men

Non-GMO formula for men

Additional Information

Store in a cool, dry place

Product Details

UPC / SKU 8 50015 03629 3
DSLD Entry Date 2022-08-23
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 272624
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →